1. P692: IMMUNE FACTORS MAINTAINING TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF IMATINIB. (23rd June 2022) Authors: Kwaśnik, P.; Zaleska, J.; Link-Lenczowska, D.; Zawada, M.; Ochrem, B.; Bober, G.; Wasilewska, E.; Mędraś, E.; Hus, I.; Szarejko, M.; Prejzner, W.; Grzybowska-Izydorczyk, O.; Klonowska-Szymczyk, A.; Sacha, T.; Giannopoulos, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗